CYBERDYNE Inc. (CYBQY)
OTCMKTS
· Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Dec 24, 2024
CYBERDYNE Revenue
CYBERDYNE had revenue of 988.00M JPY in the quarter ending September 30, 2024, a decrease of -6.62%. This brings the company's revenue in the last twelve months to 4.39B, up 14.07% year-over-year. In the fiscal year ending March 31, 2024, CYBERDYNE had annual revenue of 4.35B with 32.38% growth.
Revenue (ttm)
4.39B JPY
Revenue Growth
+14.07%
P/S Ratio
n/a
Revenue / Employee
19.35M JPY
Employees
227
Market Cap
233.83M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
Mar 31, 2020 | 1.79B | 83.00M | 4.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |